Insulin signaling is a complex process involving multiple protein-protein interactions that regulate metabolic responses. The insulin receptor, a tyrosine kinase, activates downstream signaling pathways upon insulin binding, leading to the phosphorylation of insulin receptor substrates (IRS) and subsequent activation of signaling molecules like PI3-kinase and MAP kinase. These interactions are crucial for transmitting signals to the cell, such as glucose transport and glycogen synthesis. However, insulin resistance, a key feature of type 2 diabetes and obesity, disrupts these pathways, impairing insulin's ability to regulate metabolism. Key protein interaction domains involved in insulin signaling include PH, PTB, SH2, and SH3 domains, which facilitate the binding of IRS proteins to the insulin receptor and downstream signaling molecules. These domains are essential for the specificity and efficiency of insulin signaling. Mutations in IRS-1, such as the G972R polymorphism, can impair insulin signaling by affecting the binding of the PI3-kinase subunit p85 to IRS-1, leading to reduced insulin sensitivity. Other factors contributing to insulin resistance include genetic variations in the insulin receptor, IRS proteins, and other signaling molecules, as well as environmental factors like obesity and hyperinsulinemia. Hyperinsulinemia, often associated with obesity, can lead to increased internalization and degradation of the insulin receptor, reducing its activity and impairing insulin signaling. Additionally, counterregulatory hormones like TNF-α can impair insulin signaling by increasing serine phosphorylation of IRS-1, which inhibits insulin receptor tyrosine kinase activity. Leptin, a hormone secreted by adipose tissue, plays a role in regulating insulin sensitivity and glucose homeostasis. Leptin deficiency or resistance can contribute to insulin resistance. Nutrient excess, such as hyperglycemia and hyperlipidemia, can also impair insulin signaling through mechanisms like the hexosamine pathway and activation of protein kinase C. Animal models have provided insights into the molecular mechanisms of insulin resistance, showing that targeted disruption of insulin signaling proteins can lead to severe insulin resistance and diabetes. These models highlight the importance of insulin signaling in β-cell function and glucose homeostasis. Understanding these mechanisms is crucial for developing therapeutic strategies to treat insulin resistance and type 2 diabetes.Insulin signaling is a complex process involving multiple protein-protein interactions that regulate metabolic responses. The insulin receptor, a tyrosine kinase, activates downstream signaling pathways upon insulin binding, leading to the phosphorylation of insulin receptor substrates (IRS) and subsequent activation of signaling molecules like PI3-kinase and MAP kinase. These interactions are crucial for transmitting signals to the cell, such as glucose transport and glycogen synthesis. However, insulin resistance, a key feature of type 2 diabetes and obesity, disrupts these pathways, impairing insulin's ability to regulate metabolism. Key protein interaction domains involved in insulin signaling include PH, PTB, SH2, and SH3 domains, which facilitate the binding of IRS proteins to the insulin receptor and downstream signaling molecules. These domains are essential for the specificity and efficiency of insulin signaling. Mutations in IRS-1, such as the G972R polymorphism, can impair insulin signaling by affecting the binding of the PI3-kinase subunit p85 to IRS-1, leading to reduced insulin sensitivity. Other factors contributing to insulin resistance include genetic variations in the insulin receptor, IRS proteins, and other signaling molecules, as well as environmental factors like obesity and hyperinsulinemia. Hyperinsulinemia, often associated with obesity, can lead to increased internalization and degradation of the insulin receptor, reducing its activity and impairing insulin signaling. Additionally, counterregulatory hormones like TNF-α can impair insulin signaling by increasing serine phosphorylation of IRS-1, which inhibits insulin receptor tyrosine kinase activity. Leptin, a hormone secreted by adipose tissue, plays a role in regulating insulin sensitivity and glucose homeostasis. Leptin deficiency or resistance can contribute to insulin resistance. Nutrient excess, such as hyperglycemia and hyperlipidemia, can also impair insulin signaling through mechanisms like the hexosamine pathway and activation of protein kinase C. Animal models have provided insights into the molecular mechanisms of insulin resistance, showing that targeted disruption of insulin signaling proteins can lead to severe insulin resistance and diabetes. These models highlight the importance of insulin signaling in β-cell function and glucose homeostasis. Understanding these mechanisms is crucial for developing therapeutic strategies to treat insulin resistance and type 2 diabetes.